Kenneth C. Frazier

Filings by Kenneth C. Frazier span 3 companies, the busiest being Merck & Co., Inc., Exxon Mobil Corp and Eikon Therapeutics, Inc. The record holds 9 filings, for trades running from 4 January 2016 to 4 February 2026.

Purchases make up the whole of the open-market record (1 purchase, €1.7M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants and 5 option exercises. 2026 to date brings 1 purchase and no sales.

Most recently, on 6 February 2026, the filings show an open-market purchase worth €1.7M in Eikon Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.